Multiplex Assay Kit for Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD279; PDCD1; SLEB2; HPD1P

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 95-104 99
EDTA plasma(n=5) 81-102 86
heparin plasma(n=5) 80-95 82

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 82-104% 84-92% 78-103% 84-92%
EDTA plasma(n=5) 99-105% 78-96% 90-101% 92-105%
heparin plasma(n=5) 83-97% 97-105% 99-105% 81-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:PD1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Oncotarget Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection. pubmed:28545019
CyberLeninka Потенциальные биомаркеры эффективности терапии ниволумабом при метастатическом почечно-клеточном раке :
АНАЛИЗ РЕЗУЛЬТАТОВ ЛЕЧЕНИЯ БОЛЬНЫХ МЕТАСТАТИЧЕСКИМ РАКОМ ПОЧКИ, ПОЛУЧАВШИХ АНТИ-PD-1‑ТЕРАПИЮ В РАМКАХ ПРОГРАММЫ …
International Journal of Molecular Sciences Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity Pubmed: 30699956
PLoS One Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated … Pubmed: 30807610
Cancers Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study Pubmed: 32085544
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APA751Hu02 Active Programmed Cell Death Protein 1 (PD1) Cell culture; Activity Assays.
APA751Hu01 Active Programmed Cell Death Protein 1 (PD1) Cell culture; Activity Assays.
RPA751Hu01 Recombinant Programmed Cell Death Protein 1 (PD1) Positive Control; Immunogen; SDS-PAGE; WB.
EPA751Hu61 Eukaryotic Programmed Cell Death Protein 1 (PD1) Positive Control; Immunogen; SDS-PAGE; WB.
APA751Hu61 Active Programmed Cell Death Protein 1 (PD1) Cell culture; Activity Assays.
RPA751Hu02 Recombinant Programmed Cell Death Protein 1 (PD1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA751Hu02 Polyclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC; ICC; IP.
PAA751Hu01 Polyclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC; ICC/IF
RAA751Hu23 Recombinant Antibody to Programmed Cell Death Protein 1 (PD1) WB; IF; ICC; IHC; IP; FCM.
MAA751Hu24 Monoclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC; ICC; IP.
MAA751Hu25 Monoclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC; ICC; IP.
RAA751Hu01 Recombinant Antibody to Programmed Cell Death Protein 1 (PD1) WB; IF; ICC; IHC; IP; FCM.
MAA751Hu27 Monoclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC; ICC; IP.
MAA751Hu21 Monoclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC
MAA751Hu29 Monoclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC; ICC; IP.
RAA751Hu22 Recombinant Antibody to Programmed Cell Death Protein 1 (PD1) WB; IF; ICC; IHC; IP; FCM.
MAA751Hu23 Monoclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC; ICC; IP.
MAA751Hu22 Monoclonal Antibody to Programmed Cell Death Protein 1 (PD1) WB; IHC; ICC; IP.
FAA751Hu86 FITC-Linked Anti-Programmed Cell Death Protein 1 (PD1) Monoclonal Antibody Flow cytometry.
SEA751Hu ELISA Kit for Programmed Cell Death Protein 1 (PD1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA751Hu Multiplex Assay Kit for Programmed Cell Death Protein 1 (PD1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA751Hu01 ELISA Kit DIY Materials for Programmed Cell Death Protein 1 (PD1) Main materials for "Do It (ELISA Kit) Yourself".